Callan Family Office’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Sell
228,443
-9,213
-4% -$642K 0.32% 59
2026
Q1
$15.2M Buy
237,656
+10,176
+4% +$672K 0.35% 54
2025
Q4
$14.2M Buy
227,480
+134,730
+145% +$8.25M 0.31% 58
2025
Q3
$5.56M Buy
92,750
+6,087
+7% +$355K 0.18% 134
2025
Q2
$4.94M Sell
86,663
-1,573
-2% -$84.3K 0.16% 154
2025
Q1
$4.49M Sell
88,236
-7,843
-8% -$397K 0.34% 67
2024
Q4
$4.59M Buy
96,079
+19,833
+26% +$996K 0.29% 66
2024
Q3
$4.03M Buy
76,246
+22,812
+43% +$1.16M 0.68% 31
2024
Q2
$2.64M Buy
53,434
+5,710
+12% +$284K 0.51% 35
2024
Q1
$2.39M Buy
47,724
+5
+0% +$241 0.56% 31
2023
Q4
$2.29M Sell
47,719
-3,006
-6% -$135K 0.56% 30
2023
Q3
$2.22M Buy
50,725
+10,859
+27% +$497K 0.59% 29
2023
Q2
$1.84M Buy
39,866
+1,186
+3% +$54.5K 0.49% 31
2023
Q1
$1.75M Hold
38,680
0.42% 34
2022
Q4
$1.62M Buy
+38,680
New +$1.57M 0.52% 28

Other funds holding VEA

Callan Family Office's VEA Position: Q2 2026 in Review

Callan Family Office reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 3.9% in Q2 2026, selling an estimated $642K and leaving 228,443 shares worth $16.3M. The position accounts for 0.32% of the portfolio, ranked #59.

Callan Family Office first reported a position in VEA in Q4 2022 and has held it in 15 quarters since. 2,984 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Callan Family Office held 228,443 shares of Vanguard FTSE Developed Markets ETF worth $16.3M as of Q2 2026.
  • Callan Family Office sold 9,213 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $642K.
  • Vanguard FTSE Developed Markets ETF made up 0.32% of Callan Family Office's portfolio in Q2 2026, its #59 holding.
  • Callan Family Office first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and has held it in 15 quarters since.
  • 2,984 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.